Popular Trials
Tyrosine Kinase Inhibitor
TL-895 for Myelofibrosis
Recruiting0 awardsPhase 2
Baltimore, Maryland
This trial tests TL-895, a strong oral medication that targets specific proteins to treat Myelofibrosis and Indolent Systemic Mastocytosis. It is for patients who haven't responded to other treatments or can't take certain therapies.
Tyrosine Kinase Inhibitor
Avapritinib for Systemic Mastocytosis
Recruiting0 awardsPhase 2
Birmingham, Alabama
This trial is testing a new medication called avapritinib combined with the best possible care for patients with a condition called indolent systemic mastocytosis (ISM). These patients have symptoms that are not well managed by their current treatments. Avapritinib works by blocking certain proteins that cause abnormal cell growth and activity, aiming to improve symptom control.
Popular Filters
Trials With No Placebo
Monoclonal Antibodies
MGD024 for Blood Cancers
Recruiting1 awardPhase 1
Denver, Colorado
This trial is testing a new drug called MGD024 in patients with certain blood cancers that haven't responded to other treatments. Researchers want to see if MGD024 is safe, how it works in the body, and if it helps fight cancer. Patients will receive the drug periodically, and their response will be monitored regularly.
Monoclonal Antibodies
Flotetuzumab for CD123-Positive Hematological Malignancies
Recruiting1 awardPhase 1
Duarte, California
This trial is studying the best dose and side effects of flotetuzumab for treating patients with relapsed or refractory blood cancers. Flotetuzumab is an antibody that may interfere with cancer cells' ability to grow and spread.
Kinase Inhibitor
Avapritinib + Decitabine for Systemic Mastocytosis
Recruiting1 awardPhase 1
Phoenix, Arizona
"This trial aims to study a new treatment for a challenging disease called systemic mastocytosis with an associated hematologic neoplasm. Current treatments only target one aspect of the disease, leading to progression
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.